Pentosan polysulfate sodium

Elmiron Capsules 100MG

膠囊劑TaiwanCancelledAuthorised 17 Feb 2003

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Pentosan polysulfate sodium

Elmiron Capsules 100MG

膠囊劑TaiwanCancelledAuthorised 17 Feb 2003

Ask Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

ElmironUnited States · 100MG · capsule · Janssen Pharms

CistosanBrazil · Apsen Farmaceutica S/A

THROMBOCID 1mg/g POMADASpain · 100 mg · pomada · Lacer S.A.

THROMBOCID FORTE 5 mg/g POMADASpain · 500 mg · pomada · Lacer S.A.

FibraseItaly · Capsula rigida · Teofarma S.R.L.

Hemoclar Cream 0.5GM-100GMSaudi Arabia · sanofi-aventis

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Taiwan Food and Drug Administration

TFDA, dataset 9122, Government Open Data Licence 1.0; source update and retrieval dates

Licence: Taiwan Government Open Data Licence 1.0 · Added 7 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Pentosan polysulfate sodium
Dosage form: 膠囊劑
Register: Taiwan (TFDA)
Status: Cancelled
Status in the register: 已註銷
Authorised: 17 Feb 2003
Registration: 衛署藥輸字第023657號
Marketing authorisation holder: 弘如洋生技股份有限公司
Procedure: 製　劑